NCT00557206 Oxaliplatin and Docetaxel for Recurrent or Metastatic Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00556179 Lactoserum (Dermacyd Femina®) and Prevention of Recurrence of Bacterial Vaginosis Status COMPLETED Phase PHASE4
NCT00553020 Assessment of Duration of Metabolic Effect of a Single Bolus of sc Injected Lantus Compared to NPH Insulin in Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT00551577 Neoadjuvant Chemotherapy With Carboplatin and Docetaxel in Patients With Advanced Ovarian Cancer-Prospective, Randomized Phase II Clinical Trial Status UNKNOWN Phase PHASE2
NCT00551031 Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects Status COMPLETED Phase PHASE2
NCT00549939 Alfuzosin Treatment in Children and Adolescents With Neurogenic Urinary Bladder Dysfunction Status COMPLETED Phase PHASE3
NCT00549185 Multi-dose-escalation Safety and Pharmacokinetic Study of SAR3419 as Single Agent in Relapsed/Refractory B-cell Non Hodgkin's Lymphoma Status COMPLETED Phase PHASE1
NCT00549133 Irbesartan Effects on Endothelial Dysfunction in Hypertensive Type II Diabetic Patients Comparing Atenolol Status COMPLETED Phase PHASE4
NCT00547768 Comparative Study Evaluating the Effects of Fexofenadine HCI 180 mg With Orange Juice Versus Placebo With Orange Juice in a Skin Wheal and Flare Challenge Model. Status COMPLETED Phase PHASE4
NCT00547261 Phase I Dose Finding Study of SSR97225 Given in Patients With Refractory Cancer Status TERMINATED Phase PHASE1
NCT00546325 REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic Agents Status COMPLETED Phase PHASE3
NCT00545454 Activity and Safety of Oral Administration of SSR150106XB for the Reduction of Inflammation in Patients With Active Rheumatoid Arthritis Status COMPLETED Phase PHASE2
NCT00545246 A Phase I Study of Intravenous Aflibercept in Combination With Docetaxel in Japanese Cancer Patients Status COMPLETED Phase PHASE1
NCT00544765 Docetaxel, Doxorubicin and Cyclophosphamide Versus Vinorelbine and Capecitabine in Patients Not Sufficiently / Sufficiently Responding as Preoperative Treatment of Locally Advanced or Operable Primary Breast Cancer Status COMPLETED Phase PHASE3